Stock listing

NASDAQ:SOMX Somaxon Pharmaceuticals Inc Stock

Follow Somaxon Pharmaceuticals Inc into a list and get an email when it puts out news.

Delisted NASDAQ:SOMX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:SOMX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Somaxon Pharmaceuticals Inc on 6ix

Decks
13 decks · latest Jun 15, 2011

Decks

DeckKindSlidesDate
Technical Presentation (June 2011)Technical17 slidesJun 15, 2011
Investor Presentation (May 2011)Investor deck18 slidesMay 24, 2011
13th Annual BIO CEO & Investor Conference (February 2011)Conference22 slidesFeb 14, 2011
UBS Global Life Science Conference 2010Conference22 slidesSep 21, 2010
BMO Capital Markets 10th Annual Focus on Healthcare Conference (August 2010)Conference29 slidesAug 5, 2010
BIO CEO & Investor Conference 2010Conference26 slidesFeb 8, 2010
Rodman & Renshaw 11th Annual Healthcare Conference (September 2009)Conference32 slidesSep 8, 2009
Technical Presentation (June 2008)Technical6 slidesJun 12, 2008
Technical Presentation (June 2008)Technical21 slidesJun 12, 2008
Investor Presentation (January 2008)Investor deck33 slidesJan 7, 2008
All 13 decks
DeckKindSlidesDate
Investor Presentation (November 2006)Investor deck36 slidesNov 28, 2006
Investor Presentation (October 2006)Investor deck29 slidesOct 31, 2006
Investor Presentation (April 2006)Investor deck20 slidesApr 11, 2006

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Faheem Hasnain
Other companies: Aspen Neuroscience, Inc. (Aspen Executive Chairman · Since at least Nov 2, 2026); Gossamer Bio, Inc. (Co-Founder, Chairman, and Chief Executive Officer · Since at least Feb 7, 2019); Kura Oncology, Inc. (Lead Independent Director · Since at least Apr 23, 2015); Nuvation Bio Inc. (Director · Jun 30, 2020 – Feb 10, 2021 · Past); Tocagen Inc (Director · Apr 12, 2017 – Oct 4, 2019 · Past); Immunic, Inc. (Director · Aug 11, 2016 – Sep 13, 2018 · Past); Ambit Biosciences Corp (Director · May 15, 2013 – Nov 10, 2014 · Past); Receptos Inc (President & CEO, Director · May 8, 2013 – Aug 25, 2015 · Past); Facet Biotech Corp (President & CEO, Director · Dec 9, 2008 – Apr 21, 2010 · Past); PDL BioPharma Inc (President & CEO, Director · Oct 1, 2008 – Oct 1, 2008 · Past)
Director · Sep 16, 2010 – Dec 31, 2012 · Past
Thomas Wiggans
Other companies: Pacira BioSciences, Inc. (Director · Since at least Jun 9, 2026); Jasper Therapeutics, Inc. (Chairman of the Board · Since at least Nov 1, 2023); Annexon, Inc. (Director · Since at least Jul 23, 2020); Pardes Biosciences Inc (Chief Executive Officer, Director · Mar 1, 2022 – Aug 31, 2023 · Past); Forma Therapeutics Holdings Inc (Director · Sep 7, 2020 – Oct 14, 2022 · Past); Sangamo Therapeutics, Inc. (Director · Jun 4, 2008 – Jun 1, 2011 · Past); Onyx Pharmaceuticals Inc (Director · Aug 29, 2007 – Oct 1, 2013 · Past)
Director · Jun 11, 2008 – Jul 2, 2012 · Past
Jesse I Treu
Other companies: CoLucid Pharmaceuticals Inc (Director · May 5, 2015 – May 11, 2015 · Past); Aldeyra Therapeutics, Inc. (Director · May 1, 2014 – Jun 9, 2020 · Past); Tandem Diabetes Care, Inc. (Director · Nov 13, 2013 – Nov 15, 2016 · Past); Veracyte, Inc. (Director · Oct 29, 2013 – Feb 28, 2019 · Past); Tobira Therapeutics Inc (Director · Aug 21, 2013 – Jan 1, 2015 · Past)
Director · Mar 3, 2010 – Jun 9, 2010 · Past
David Hale
Other companies: Dermata Therapeutics, Inc. (Lead Director · Since at least Aug 12, 2021); Oncternal Therapeutics Inc (Director · Jun 7, 2019 – Jun 20, 2024 · Past); Histogen Inc (Director · Jul 24, 2013 – Jun 27, 2019 · Past); Santarus Inc (Director · Mar 21, 2012 – Jan 2, 2014 · Past)
Director · Apr 2, 2012 – Dec 31, 2012 · Past
Richard W Pascoe
Other companies: Histogen Inc (President, CEO & Director, Director · May 26, 2020 – Mar 30, 2021 · Past); Zevra Therapeutics, Inc. (Chief Executive Officer, Director · Apr 15, 2015 – Mar 9, 2023 · Past); Apricus Biosciences Inc (CEO & Secretary, Director · Mar 18, 2013 – Jan 23, 2019 · Past)
President and CEO, Director · Nov 28, 2008 – Dec 31, 2012 · Past
Tran B. Nguyen
Other companies: Prothena Corporation plc (Chief Financial Officer · Since at least Mar 25, 2013); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past); Sierra Oncology Inc (Director · Mar 18, 2016 – Jun 11, 2019 · Past)
SVP and CFO · Apr 12, 2010 – Dec 31, 2012 · Past
Matthew Onaitis
Other companies: Cidara Therapeutics Inc (Gnrl Counsel, CFO & Secretary · Jul 1, 2016 – Mar 29, 2018 · Past); Trius Therapeutics Inc (General Counsel · May 31, 2012 – Sep 11, 2013 · Past)
SVP, General Counsel · May 15, 2006 – Dec 31, 2012 · Past
Meg McGilleyVP, CFO, Treasurer · Jan 6, 2006 – Feb 17, 2009 · Past
Michael D AllenSVP, Sales and Marketing · Sep 30, 2011 – Sep 30, 2011 · Past
Terrell CobbDirector · Dec 31, 2005 – Dec 31, 2012 · Past

Open People

Log in to ask 6ix AI your own questions about Somaxon Pharmaceuticals Inc.